Prognostic scores for patients with salivary adenoid cystic carcinoma without lymph node metastasis.


Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
10 2023
Historique:
received: 07 04 2023
revised: 16 05 2023
accepted: 02 07 2023
medline: 18 8 2023
pubmed: 25 7 2023
entrez: 24 7 2023
Statut: ppublish

Résumé

Adenoid cystic carcinoma (AdCC) of salivary gland grows relatively slowly, but occasionally develops distant metastasis. Although cervical lymph node metastasis (LNM) has been reported as a strong prognostic factor, most of AdCC do not have LNM. In this study, we investigated the prognostic factors to predict disease free survival (DFS), distant metastasis free survival (DMFS), and overall survival (OS) for 175 patients surgically treated for AdCC without LNM, and developed prognostic score (PS) determined as number of positive prognostic factors. The following emerged as significant prognostic factors: positive surgical margin in DFS, pT3/4 and positive surgical margin in DMFS, and positive surgical margin and high-histological grade in OS. 10-year DFS rates were 56.4% in PS0, and 19.1% in PS1 (p < 0.0001). 10-year DMFS rates were 86.3% in PS0, 56.4% in PS1, and 30.7% in PS2 (p < 0.0001). 10-year OS rates were 100% in PS0, 73.3% in PS1, and 38.8% in PS2 (p < 0.0001).

Identifiants

pubmed: 37487445
pii: S1368-8375(23)00187-2
doi: 10.1016/j.oraloncology.2023.106491
pii:
doi:

Types de publication

Letter Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106491

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Hikari Shimoda (H)

Department of Otolaryngology‑Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan; Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Masanori Teshima (M)

Department of Otolaryngology‑Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Takayuki Murase (T)

Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Toshitaka Nagao (T)

Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.

Kimihide Kusafuka (K)

Department of Pathology, Shizuoka General Hospital, Shizuoka, Japan.

Masato Nakaguro (M)

Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.

Makoto Urano (M)

Department of Diagnostic Pathology, Bantane Hospital, Fujita Health University School of Medicine, Nagoya, Japan.

Ken-Ichi Taguchi (KI)

Department of Pathology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.

Hidetaka Yamamoto (H)

Department of Anatomic Pathology, Graduate of School of Medical Science, Kyushu University, Fukuoka, Japan.

Satoshi Kano (S)

Department of Otolaryngology‑Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Yuichiro Tada (Y)

Department of Head and Neck Oncology and Surgery, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.

Kiyoaki Tsukahara (K)

Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.

Kenji Okami (K)

Department of Otolaryngology‑Head and Neck Surgery, Tokai University School of Medicine, Isehara, Japan.

Tetsuro Onitsuka (T)

Division of Head and Neck Surgery, Shizuoka Cancer Center, Shizuoka, Japan.

Yasushi Fujimoto (Y)

Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Otorhinolaryngology-Head and Neck Surgery, Aichi Medical University School of Medicine, Nagakute, Japan.

Daisuke Kawakita (D)

Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Kazuo Sakurai (K)

Department of Otorhinolaryngology, Fujita Health University, Okazaki Medical Center, Okazaki, Japan.

Nobuhiro Hanai (N)

Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Toru Nagao (T)

Department of Maxillofacial Surgery, School of Dentistry, Aichi-Gakuin University, Nagoya, Japan.

Ryo Kawata (R)

Department of Otorhinolaryngology‑Head and Neck Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

Naohito Hato (N)

Department of Otolaryngology, Ehime University School of Medicine, Toon, Japan.

Ken-Ichi Nibu (KI)

Department of Otolaryngology‑Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan. Electronic address: nibu@med.kobe-u.ac.jp.

Hiroshi Inagaki (H)

Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Electronic address: hinagaki@med.nagoya-cu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH